Trademark: 74361428
Status Date
Saturday, February 14, 2009
Registration Number
2157038
Registration Date
Tuesday, May 12, 1998
Filing Date
Friday, February 19, 1993
Published for Opposition
Tuesday, October 29, 1996
Cancellation Date
Saturday, February 14, 2009
5 humanized antibodies for treatment of autoimmune conditions, inflammatory conditions, viral infections, myocardial infarctions and arterial thromboses; treatment and diagnosis of cancers
Feb 14, 2009
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Aug 17, 2007
Case File In Ticrs
Jun 15, 2004
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
May 12, 2004
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
May 12, 2004
Teas Section 8 & 15 Received
May 12, 1998
Registered-Principal Register
Mar 19, 1998
Allowed Principal Register - Sou Accepted
Jan 14, 1988
Statement Of Use Processing Complete
Jan 21, 1998
Use Amendment Filed
Aug 12, 1997
Extension 1 Granted
Jul 21, 1997
Extension 1 Filed
Jan 21, 1997
Noa Mailed - Sou Required From Applicant
Oct 29, 1996
Published For Opposition
Sep 27, 1996
Notice Of Publication
Jul 29, 1996
Approved For Pub - Principal Register
Jul 29, 1996
Assigned To Examiner
Jul 23, 1996
Assigned To Examiner
Jun 21, 1994
Letter Of Suspension Mailed
Jun 20, 1994
Assigned To Examiner
Jun 20, 1994
Previous Allowance Count Withdrawn
Jun 20, 1994
Assigned To Examiner
Jun 8, 1994
Jurisdiction Restored To Examining Attorney
Apr 21, 1994
Assigned To Examiner
Dec 3, 1993
Extension Of Time To Oppose Received
Nov 2, 1993
Published For Opposition
Oct 1, 1993
Notice Of Publication
Aug 20, 1993
Approved For Pub - Principal Register
Jul 14, 1993
Correspondence Received In Law Office
May 21, 1993
Non-Final Action Mailed
May 10, 1993
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
